{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:07:04Z","timestamp":1779368824324,"version":"3.53.0"},"reference-count":85,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ANZ Journal of Surgery"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer is a globally prevalent malignancy with a marked male predominance. Over the past decade, the androgen receptor has been investigated as a potential contributor to bladder cancer pathophysiology. Androgen receptor expression is most commonly assessed via immunohistochemistry, but its association with pathological features and clinical outcomes remains uncertain. This meta\u2010analysis aimed to evaluate whether androgen receptor expression assessed by immunohistochemistry is associated with pathological characteristics of urothelial bladder cancer, with exploratory assessment of reported prognostic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of MEDLINE, EMBASE and Cochrane was performed between January 1st 2000 and October 31st 2024. Papers comparing AR expression using immunohistochemistry to bladder urothelial cancer specimens stratified by grade, stage, gender and survival outcomes were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total 16 papers were included with 2108 patient samples. No correlation was found between androgen receptor expression and grade (OR 0.83, 95% CI 0.43\u20131.59), stage (OR 0.94, 95% CI 0.38\u20132.35), progression free survival (HR 0.84, 95% CI 0.45\u20131.59) or recurrence free survival (HR 0.81, 95% CI 0.49\u20131.31). Male bladder cancer specimens were more likely to express the androgen receptor than female bladder cancer specimens (OR 1.40, 95% CI 1.03\u20131.89).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Immunohistochemistry as a measure of androgen receptor expression does not show a consistent association with pathological features and demonstrates no reproducible prognostic signal in the available literature. Male bladder cancer specimens express AR more frequently than female bladder cancer specimens. The significance of this needs to be correlated to further research into normal androgen receptor expression patterns in the urinary bladder and more precise measures of androgen receptor activity than immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ans.70752","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:32:41Z","timestamp":1779366761000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Androgen Receptor Expression in Urothelial Bladder Cancer\u2014A Systematic Review and Meta\u2010Analysis"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-8914","authenticated-orcid":false,"given":"Alex","family":"Buckby","sequence":"first","affiliation":[{"name":"Flinders University, College of Medicine and Public Health  Adelaide South Australia Australia"},{"name":"Department of Urology Southern Adelaide Local Health Network, Flinders Medical Centre, 1 Flinders Drive  Bedford Park South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Gholami","sequence":"additional","affiliation":[{"name":"Department of Urology Southern Adelaide Local Health Network, Flinders Medical Centre, 1 Flinders Drive  Bedford Park South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hong","sequence":"additional","affiliation":[{"name":"Flinders University, College of Medicine and Public Health  Adelaide South Australia Australia"},{"name":"Department of Urology Southern Adelaide Local Health Network, Flinders Medical Centre, 1 Flinders Drive  Bedford Park South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O'Callaghan","sequence":"additional","affiliation":[{"name":"Flinders University, College of Medicine and Public Health  Adelaide South Australia Australia"},{"name":"Department of Urology Southern Adelaide Local Health Network, Flinders Medical Centre, 1 Flinders Drive  Bedford Park South Australia Australia"},{"name":"The University of Adelaide, Discipline of Medicine  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3"},{"key":"e_1_2_15_4_1","volume-title":"WHO Classification of Tumours. Urinary and Male Genital Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"e_1_2_15_5_1","volume-title":"Presented at the EAU Annual Congress Paris 2024","author":"EAU Guidelines Office","year":"2024"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-230099"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.07.027"},{"issue":"3","key":"e_1_2_15_8_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic Burden of Bladder Cancer Across the European Union","volume":"69","author":"Leal J.","year":"2016","journal-title":"European Urology"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000078"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.07.016"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-526"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-150042"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11401.x"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.04.110"},{"issue":"6","key":"e_1_2_15_15_1","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.juro.2006.07.147","article-title":"Are Patients Aware of the Association Between Smoking and Bladder Cancer?","volume":"176","author":"Nieder A. M.","year":"2006","journal-title":"Journal of Urology"},{"key":"e_1_2_15_16_1","unstructured":"Australian Government \u2010 Cancer Australia \u201cBladder Cancer Statistics in Australia 2022 \u201dupdated August 18 2022 https:\/\/www.canceraustralia.gov.au\/cancer\u2010types\/bladder\u2010cancer\/statistics."},{"issue":"23","key":"e_1_2_15_17_1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.21037\/atm-20-2108","article-title":"An Overview of Patients With Urothelial Bladder Cancer Over the Past Two Decades: A Surveillance, Epidemiology, and End Results (SEER) Study","volume":"8","author":"Zang Y.","year":"2020","journal-title":"Annals of Translational Medicine"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/21681805.2015.1085089"},{"issue":"7","key":"e_1_2_15_19_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association Between Smoking and Risk of Bladder Cancer Among Men and Women","volume":"306","author":"Freedman N. D.","year":"2011","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.10.003"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.037"},{"issue":"20","key":"e_1_2_15_22_1","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/jnci\/82.20.1636","article-title":"Unexplained Excess Risk of Bladder Cancer in Men","volume":"82","author":"Hartge P.","year":"1990","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00761-y"},{"issue":"2","key":"e_1_2_15_24_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00256185","article-title":"Effects of Sex Hormones on Development of Urinary Bladder Tumours in Rats Induced by N\u2010Butyl\u2010N\u2010(4\u2010Hydroxybutyl) Nitrosamine","volume":"3","author":"Okajima E.","year":"1975","journal-title":"Urological Research"},{"issue":"3","key":"e_1_2_15_25_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000474484","article-title":"Promoting Effects and Mechanisms of Action of Androgen in Bladder Carcinogenesis in Male Rats","volume":"31","author":"Imada S.","year":"1997","journal-title":"European Urology"},{"issue":"7","key":"e_1_2_15_26_1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/djk113","article-title":"Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals","volume":"99","author":"Miyamoto H.","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.01.018"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148851"},{"issue":"10","key":"e_1_2_15_29_1","first-page":"2041","article-title":"Enzalutamide as an Androgen Receptor Inhibitor Prevents Urothelial Tumorigenesis","volume":"7","author":"Kawahara T.","year":"2017","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082155"},{"issue":"5","key":"e_1_2_15_31_1","first-page":"461","article-title":"GATA3 in the Urinary Bladder: Suppression of Neoplastic Transformation and Down\u2010Regulation by Androgens","volume":"4","author":"Li Y.","year":"2014","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.27631"},{"issue":"51","key":"e_1_2_15_33_1","first-page":"E3588","article-title":"CD24 Expression Is Important in Male Urothelial Tumorigenesis and Metastasis in Mice and Is Androgen Regulated","volume":"109","author":"Overdevest J. B.","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"e_1_2_15_34_1","first-page":"578","article-title":"Androgen Receptor (AR) Promotes Male Bladder Cancer Cell Proliferation and Migration via Regulating CD24 and VEGF","volume":"8","author":"Ding G.","year":"2016","journal-title":"American Journal of Translational Research"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0786"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.02.2554"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9994"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3781"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.03.008"},{"issue":"1","key":"e_1_2_15_40_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13046-019-1258-0","article-title":"ASC\u2010J9 Increases the Bladder Cancer Chemotherapy Efficacy via Altering the Androgen Receptor (AR) and NF\u2010\u03baB Survival Signals","volume":"38","author":"Huang C. P.","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000092238.15685.10"},{"key":"e_1_2_15_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.06.007"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-1055-T"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1389"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174746"},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108602"},{"key":"e_1_2_15_48_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.03.025"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.01.033"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09834.x"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10706.x"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2014.55.5.1214"},{"issue":"3","key":"e_1_2_15_54_1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5114\/pjp.2018.79543","article-title":"The Prognostic Significance of Androgen Receptor and Beta\u2010Catenin Immunohistochemical Expression in Urothelial Carcinoma With and Without Detrusor Muscle Invasion From an Egyptian Institution","volume":"69","author":"Elzamy S.","year":"2018","journal-title":"Polish Journal of Pathology"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-018-0431-7"},{"issue":"2","key":"e_1_2_15_56_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5430\/jst.v10n2p22","article-title":"Androgen Receptor Expression in the Urinary Bladder Urothelial Carcinoma and Its Relation to Known Prognostic Factors","volume":"10","author":"El\u2010Taher E. T.","year":"2020","journal-title":"Journal of Solid Tumors"},{"issue":"1","key":"e_1_2_15_57_1","first-page":"e6715","article-title":"Androgen Receptor: Evaluation and Correlation With Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder","volume":"12","author":"Mumtaz S.","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"e_1_2_15_58_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12301-019-0014-1","article-title":"Evaluation of Androgen Receptor Status in Urothelial Carcinoma of the Urinary Bladder in Egyptian Patients: An Immunohistochemical Study","volume":"26","author":"Wagih M.","year":"2020","journal-title":"African Journal of Urology"},{"issue":"3","key":"e_1_2_15_59_1","first-page":"325","article-title":"Implications of Androgen Receptor and FUS Expression on Tumor Progression in Urothelial Carcinoma","volume":"36","author":"Abd Raboh N. M.","year":"2021","journal-title":"Histology and Histopathology"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03358-x"},{"issue":"4","key":"e_1_2_15_61_1","article-title":"Immunohistochemical Expression of Androgen Receptors in Urothelial Carcinoma of Urinary Bladder. Is It Significant? Experience From Coastal India","volume":"95","author":"Jindal D.","year":"2023","journal-title":"Archivio Italiano di Urologia, Andrologia"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05348-z"},{"key":"e_1_2_15_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijso.2023.100645"},{"key":"e_1_2_15_64_1","doi-asserted-by":"publisher","DOI":"10.4103\/iju.iju_324_23"},{"key":"e_1_2_15_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411"},{"key":"e_1_2_15_66_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/B978-0-12-822455-7.00011-8","volume-title":"Neuro\u2010Urology Research","author":"Turco A. E.","year":"2023"},{"key":"e_1_2_15_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(96)03819-1"},{"key":"e_1_2_15_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66041-7"},{"issue":"4","key":"e_1_2_15_69_1","first-page":"1261","article-title":"Localization of Androgen and Estrogen Receptors in Rat and Primate Tissues","volume":"15","author":"Pelletier G.","year":"2000","journal-title":"Histology and Histopathology"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.1930140114"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01811.x"},{"issue":"6","key":"e_1_2_15_72_1","first-page":"1052","article-title":"Outcome of Surgical Management and Pathogenesis of Female Primary Bladder Neck Obstruction","volume":"51","author":"Zhang X. P.","year":"2019","journal-title":"Beijing Da Xue Xue Bao. Yi Xue Ban"},{"key":"e_1_2_15_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040594"},{"key":"e_1_2_15_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hys072"},{"key":"e_1_2_15_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajur.2020.05.011"},{"issue":"6","key":"e_1_2_15_76_1","first-page":"1968","article-title":"Role of Steroid Hormone Receptors in Formation and Progression of Bladder Carcinoma: A Case\u2010Control Study","volume":"11","author":"Mashhadi R.","year":"2014","journal-title":"Urology Journal"},{"key":"e_1_2_15_77_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7358"},{"key":"e_1_2_15_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040746"},{"key":"e_1_2_15_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.01.005"},{"key":"e_1_2_15_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2017.01.013"},{"issue":"1","key":"e_1_2_15_81_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12885-019-5512-9","article-title":"Androgen Receptor mRNA Expression Is a Predictor for Recurrence\u2010Free Survival in Non\u2010Muscle Invasive Bladder Cancer","volume":"19","author":"Yasui M.","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"e_1_2_15_82_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/s12885-020-07218-0","article-title":"Androgen Receptor mRNA Levels Determine the Prognosis in Triple\u2010Negative Breast Cancer Patients","volume":"20","author":"Govindan S.","year":"2020","journal-title":"BMC Cancer"},{"key":"e_1_2_15_83_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9020020"},{"issue":"7","key":"e_1_2_15_84_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1200\/JCO.2019.37.7_suppl.471","article-title":"Results From a Phase I\/Ib Trial of Enzalutamide and Gemcitabine and Cisplatin in Metastatic Bladder Cancer (mBC)","volume":"37","author":"Gupta S.","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_15_85_1","unstructured":"P.Toren W.Kassouf M.Huynh J.\u2010B.Lattouf andG.Kulkarni \u201cA Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non\u2010Muscle Invasive Bladder Cancer (BicaBCa) \u201d2024."},{"key":"e_1_2_15_86_1","unstructured":"\u201cTargeting Androgen Signaling in Urothelial Cell Carcinoma \u2010 Neoadjuvant (TASUC\u2010Neo): A Pilot Study of Degarelix in Combination With Neoadjuvant Gemcitabine and Cisplatin in Muscle\u2010Invasive Urothelial Cell Carcinoma of the Bladder [Internet] \u201d2023 https:\/\/clinicaltrials.gov\/study\/NCT05839119."}],"container-title":["ANZ Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ans.70752","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ans.70752","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ans.70752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:32:48Z","timestamp":1779366768000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ans.70752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":85,"alternative-id":["10.1111\/ans.70752"],"URL":"https:\/\/doi.org\/10.1111\/ans.70752","archive":["Portico"],"relation":{},"ISSN":["1445-1433","1445-2197"],"issn-type":[{"value":"1445-1433","type":"print"},{"value":"1445-2197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2025-12-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ans.70752"}}